Laugier-Hunziker Syndrome (LHS)

Laugier-Hunziker Syndrome (LHS)

Julie Scott, DNP
Julie Scott, DNP
Laugier-Hunziker Syndrome |cancerGO

What is Laugier-Hunziker Syndrome (LHS)

Laugier-Hunziker Syndrome (LHS) is a rare disorder that affects the pigment of the skin and mucous membranes of the mouth. LHS is also known as idiopathic lenticular mucocutaneous pigmentation.

LHS is a benign (non-cancerous) condition and does not cause any serious health problems. The main symptom of LHS is the appearance of dark pigmentation on the lips, inside of the mouth, and sometimes on the fingers and toes. The pigmentation is typically brown or black and appears as small, flat spots or patches.

Causes:

The exact cause of LHS is unknown, but it is thought to be a combination of genetic and environmental factors. Some cases of LHS have been associated with mutations in the TERT gene, which is involved in the process of cell division and aging. Other cases have been linked to exposure to certain medications, such as nonsteroidal anti-inflammatory drugs (NSAIDs) and hormonal therapies.

Diagnosis:

LHS is usually diagnosed based on the pigmentation pattern which is characteristic of the disorder, as well as a thorough medical history. In some cases, a skin biopsy may be performed to rule out other conditions that may cause similar symptoms.

Treatment:

Treatment for LHS is usually not necessary as the condition does not cause any health problems. However, if the pigmentation is causing cosmetic concerns, treatment options such as laser therapy, cryotherapy, and topical creams may be considered.

It is important to note that LHS does not increase the risk of developing skin cancer or other health problems. However, it is still important to practice good sun protection habits, such as wearing protective clothing and sunscreen, to prevent damage to the skin

 

Julie Scott, DNP
Julie Scott, DNP
Julie is an oncology certified Oncology Nurse Practitioner with over a decade of medical oncology experience. In addition to her clinical work, she is an accomplished healthcare writer providing oncology content for various publications. She also serves as an adjunct faculty member for a Master's nursing program and a chair for Doctoral nursing students.

Download our
mobile app

Share this post
You may also like
Articles
What is mantle cell lymphoma?
December 22, 2022

Mantle cell lymphoma is a type of non-Hodgkin's lymphoma cancer that grows in the lymphatic system. The lymphatic system is responsible for moving fluids around the body and transporting the immune system. Mantle cell lymphoma is not common and is responsible for less than 10% of lymphoma diagnoses. It’s most…

Julie Scott, DNP

author

Articles
Breast cancer systemic treatment
November 8, 2022

The exact treatment prescribed for you will be based on the stage and characteristics of your breast cancer. It's important to talk to your oncology team if you have any specific questions about your particular treatment.  Treatment is often classified into local therapy or systemic therapy. Local therapy means that…

Julie Scott, DNP

author

Articles
Non-Small Cell Cancer (NSCLC)
November 7, 2022

Approximately  85% of lung cancer cases are considered NSCLC, which arises from the lung's epithelial cells, a type of cell that lines the organ surface. Several types of non-small cell lung (NSCL) include adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. Non-small-cell lung cancer is when the cells in your…

Zain Syed

author

cancerGO gives you access to a community

Where are people to listen, answer questions, share information, and offer valuable and timely advice